Study to Determine the Antibody Response to 500µg G17DT in Treatment of Patients With Gastric Cancer

NCT02450032 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Cancer Advances Inc.